<ul><li>Researchers in Australia have developed a nanosensor with 95% accuracy to detect the onset of gestational diabetes in early pregnancy.</li><li>The nanosensor uses superparamagnetic 'nanoflower' technology to isolate and detect biomarkers associated with complications in early pregnancy.</li><li>The sensor can detect protein molecules carried by extracellular vesicles (EVs), enabling the identification of potential complications such as preterm birth, gestational diabetes, and preeclampsia.</li><li>The development of this nanosensor has the potential to revolutionize risk assessment and improve clinical decision-making in obstetric care.</li></ul>

Nanosensor predicts risk of complications in early pregnancy

Discover more